PURPOSE: We performed the first comprehensive, population-based brachytherapy (BT) Patterns of Care Study in the Australian setting.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Herein we report on prostate BT and assess the technical quality of BT practice, focusing on whether a caseload effect could be identified in New South Wales (NSW).
MATERIAL AND METHODS: Site visits were made to all radiation oncology departments in NSW that delivered prostate BT, collecting relevant data on NSW residents treated with prostate BT in 2003. Overall quality of NSW prostate BT treatment was assessed using benchmarks including treatment of appropriate prostate cancer disease risk category, absence of (relative) physical contraindications, optimal planned and treated dosimetry, and pre-/post-implant planning/CT. Quality was compared between higher and lower caseload departments.
RESULTS: One hundred and fifty-seven (67%) patients underwent temporary BT and 79 (33%) permanent seed BT. Prostate BT was concentrated in five departments, with three of four departments with active programmes treating greater than the recommended 25 cases. Rates of concordance with quality benchmarks were high (85-99%) with no consistent caseload effect identified.
CONCLUSIONS: Prostate BT in NSW in 2003 was generally of high quality and a caseload effect on quality could not be identified. This may be because the number of departments was insufficient to determine a caseload effect, or because the prostate BT was largely concentrated in a small number of high caseload departments.
Thompson SR, Delaney GP, Gabriel GS, Izard MA, Hruby G, Jagavkar R, Bucci J, Barton MB. Are you the author?
Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Sydney; Department of Radiation Oncology, Prince of Wales Hospital, Sydney; University of New South Wales, Faculty of Medicine, Sydney; University of Western Sydney, Faculty of Medicine, Sydney; Faculty of Medicine, University of Sydney, Sydney; Mater Hospital Radiotherapy, North Sydney; Sydney Cancer Centre, Sydney; Department of Radiation Oncology, St Vincent's Hospital, Sydney; Cancer Care Centre, St George Hospital, Sydney, NSW, Australia.
Reference: J Contemp Brachytherapy. 2015 Jan;6(4):344-9.